Drug Type Biological products |
Synonyms RCT-201 |
Target |
Mechanism CFTR gene modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization ReCode Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystic Fibrosis | Discovery | US | - | |
Cystic Fibrosis | Discovery | US | - | |
Cystic Fibrosis | Discovery | US | - | |
Cystic Fibrosis | Discovery | US | - | |
Cystic Fibrosis | Discovery | US | - | |
Cystic Fibrosis | Discovery | US | ReCode Therapeutics, Inc.Startup | - |
Cystic Fibrosis | Discovery | GB | - |